Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Price:
1.06
USD
-11.67%
Market Closed
Market Cap:
$5.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
Income Statement
Earnings Waterfall
Aspire Biopharma Holdings Inc
Aspire Biopharma Holdings Inc
Income Statement
Aspire Biopharma Holdings Inc
Aspire Biopharma Holdings Inc
Currency: USD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(4)
|
(4)
|
(3)
|
(16)
|
(16)
|
(17)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(4)
|
(4)
|
(3)
|
(16)
|
(16)
|
(16)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
|
| Operating Income |
(0)
N/A
|
(0)
-231%
|
(1)
-56%
|
(1)
-46%
|
(1)
-21%
|
(1)
+1%
|
(1)
-5%
|
(1)
-8%
|
(4)
-164%
|
(4)
-6%
|
(4)
-8%
|
(3)
+24%
|
(16)
-422%
|
(16)
-2%
|
(17)
-3%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
0
|
2
|
4
|
7
|
9
|
8
|
6
|
3
|
1
|
1
|
(0)
|
(1)
|
(2)
|
(3)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(9)
|
(9)
|
(9)
|
(9)
|
|
| Pre-Tax Income |
(0)
N/A
|
0
N/A
|
1
+11 000%
|
3
+201%
|
6
+89%
|
8
+27%
|
7
-14%
|
4
-35%
|
(1)
N/A
|
(3)
-274%
|
(4)
-14%
|
(13)
-234%
|
(26)
-107%
|
(27)
-5%
|
(29)
-5%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
0
|
1
|
3
|
6
|
8
|
7
|
4
|
(1)
|
(3)
|
(4)
|
(13)
|
(26)
|
(27)
|
(29)
|
|
| Net Income (Common) |
(0)
N/A
|
0
N/A
|
1
+11 000%
|
3
+201%
|
6
+89%
|
8
+27%
|
7
-14%
|
4
-35%
|
(1)
N/A
|
(3)
-274%
|
(4)
-14%
|
(13)
-234%
|
(26)
-107%
|
(27)
-5%
|
(29)
-5%
|
|
| EPS (Diluted) |
-0.23
N/A
|
0
N/A
|
1.23
N/A
|
4.21
+242%
|
7.01
+67%
|
16.28
+132%
|
30.42
+87%
|
9.31
-69%
|
-3.9
N/A
|
-15.53
-298%
|
-19.35
-25%
|
-60.83
-214%
|
-27.46
+55%
|
-22.21
+19%
|
-23.18
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
